Dermaval® (Fruit & Vegetable Polyphenol Blend — FutureCeuticals)

Evidence Level
Preliminary
1 Clinical Trial
2 Documented Benefits
1/5 Evidence Score

Dermaval® is a proprietary blend of fruit and vegetable concentrates from FutureCeuticals (Momence, Illinois), sold as a beauty-from-within ingredient. At launch the company listed pomegranate extract, asparagus, okra, coffee, acerola cherry, camu camu, Sophora japonica, açaí and mangosteen concentrates among its contents. In the published analysis, punicalagins (the main pomegranate polyphenols) made up about 20% of the blend, with smaller amounts of chlorogenic acids, quercetin and vitamin C. It was designed to block human neutrophil elastase, an enzyme that breaks down elastin. The only published human study gave 20 healthy adults one 50 mg dose before a glucose drink, on a fixed day order without randomization, and found the usual rise in blood elastase activity was prevented. No study has measured skin itself.

Studied Dose A single 50 mg dose taken 15 minutes before a 75 g glucose drink. No longer-term dose has been studied in a published trial.
Active Compound Punicalagins (about 202 mg/g), chlorogenic acids (about 16 mg/g), quercetin (about 14 mg/g) and vitamin C (about 9 mg/g), as measured in the published study.

Benefits

Blood elastase, an enzyme that breaks down skin elastin, after a sugar load

In 20 healthy adults, a 75 g glucose drink raised blood neutrophil elastase activity to about 1.7 times its starting level within an hour. When the same people took 50 mg of Dermaval 15 minutes before the glucose on another day, the rise did not occur. Elastase breaks down elastin in skin, but skin firmness or elasticity has never been measured with this product.

Pomegranate-rich polyphenol blend

The blend is dominated by punicalagins, the main polyphenols of pomegranate, at about 20% by weight, with smaller amounts of chlorogenic acids, quercetin and vitamin C. No study has measured antioxidant status in people taking Dermaval.

Mechanism of action

1

Neutrophil elastase inhibition

Human neutrophil elastase is an enzyme that breaks down elastin and other proteins. The blend was designed to inhibit it, and in the single human study it prevented the glucose-driven rise in blood elastase activity.

2

Glucose and elastase

Blood elastase activity rose after a sugar load in the study, and Dermaval did not change blood glucose levels, so the effect was not due to slower sugar absorption. The authors say the direct mechanism still needs study.

Clinical trials

1
Single 50 mg dose and glucose-induced elastase activity
PubMed

Acute 3 day study in which each person served as their own control: water and an empty capsule on day 1, 75 g glucose on day 2, and 50 mg Dermaval followed by 75 g glucose on day 3. The days ran in a fixed order, no randomization or blinding is described, and FutureCeuticals funded it. (Reyes-Izquierdo et al. 2014, Nutrition and Dietary Supplements)

20 healthy adults (10 men, 10 women) aged 25 to 35 with normal BMI.

Glucose alone raised blood neutrophil elastase activity to about 171% of baseline at 60 minutes. With Dermaval first, activity stayed at 100% and 88% of baseline (P = 0.005 at 60 minutes and P = 0.03 at 120 minutes versus the glucose-only day). Blood glucose was the same on both glucose days. No skin outcome was measured.

Side effects and drug interactions

Common Potential side effects

The one published study gave a single dose and did not report on side effects.
Mild stomach upset is possible with concentrated polyphenol extracts.
People allergic to any of the listed fruits or vegetables should check the full ingredient panel.
No long-term safety data exist.

Important Drug interactions

No interactions have been studied for Dermaval.
Ask a doctor before combining with prescription medicines, including blood thinners.

Frequently asked questions about Dermaval® (Fruit & Vegetable Polyphenol Blend — FutureCeuticals)

What is Dermaval?

Dermaval® is a proprietary blend of fruit and vegetable concentrates from FutureCeuticals (Momence, Illinois), sold as a beauty-from-within ingredient. At launch the company listed pomegranate extract, asparagus, okra, coffee, acerola cherry, camu camu, Sophora japonica, açaí and mangosteen concentrates among its conte…

What is Dermaval used for?

Dermaval is researched primarily for Hair, Skin & Nails. In 20 healthy adults, a 75 g glucose drink raised blood neutrophil elastase activity to about 1.7 times its starting level within an hour.

What is the recommended dosage of Dermaval?

The clinically studied dose is A single 50 mg dose taken 15 minutes before a 75 g glucose drink. No longer-term dose has been studied in a published trial. Always follow the product label and check with a healthcare provider for personal advice.

Is Dermaval safe, and does it have side effects?

For most healthy adults, Dermaval is well tolerated at studied doses. Reported effects can include: The one published study gave a single dose and did not report on side effects. Mild stomach upset is possible with concentrated polyphenol extracts. It may also interact with some medications. Dermaval is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Dermaval interact with any medications?

Possible interactions include: No interactions have been studied for Dermaval. Ask a doctor before combining with prescription medicines, including blood thinners. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Dermaval?

NutraSmarts rates the evidence for Dermaval as Preliminary (1 out of 5). It is backed by 1 clinical trial and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Reyes-Izquierdo T, Nemzer B, Argumedo R, Shu C, Pietrzkowski Z. Dermaval™ inhibits glucose-induced neutrophil elastase activity in healthy subjects. Nutrition and Dietary Supplements. 2014;6:1-7. doi: 10.2147/NDS.S53838.SourceUsed to support: Peer reviewed but not PubMed-indexed. Acute study in 20 healthy adults who served as their own controls over 3 days: no treatment, 75 g glucose, then 50 mg Dermaval 15 minutes before 75 g glucose. Glucose raised blood neutrophil elastase activity to about 171% of baseline at 60 minutes, and Dermaval prevented the rise (P = 0.005 at 60 minutes, P = 0.03 at 120 minutes). Blood glucose was unchanged by Dermaval. The blend contained about 202 mg/g punicalagins, 16 mg/g chlorogenic acids, 14 mg/g quercetin and 9 mg/g vitamin C. Funded by FutureCeuticals; one author works there.
  2. NutraIngredients. New beauty food ingredient inhibits elastase. NutraIngredients. 2010;Published 21 May 2010..SourceUsed to support: Trade press article, not PubMed-indexed and not peer reviewed. Gives the launch ingredient list of Dermaval: pomegranate extract, asparagus, okra (Abelmoschus esculentus), a tropical berry blend, coffee (Coffea arabica), acerola cherry, camu camu, Sophora japonica, açaí and mangosteen concentrates.